Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes por Walter Suárez Carmona | Jun 23, 2025
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity por Walter Suárez Carmona | Jun 23, 2025
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial por Walter Suárez Carmona | Jun 23, 2025
Re-evaluating the concept of remission in type 2 diabetes: a call for patient-centric approaches por Walter Suárez Carmona | Jun 20, 2025
METRNL represses beta‐to‐alpha cell trans‐diferentiation to maintain beta cell function under diabetic metabolic stress in mice por Walter Suárez Carmona | Jun 20, 2025
